Changes in proteomic profiles in different prostate lobes of male rats throughout growth and development and aging stages of the life span

Prostate

Volumn 73, Issue 4, 2013, Pages 363-375

  Das, Arunangshu ^a   Bortner Jr , James D ^a   Aliaga, Cesar A ^a   Baker, Aaron ^a   Stanley, Anne ^a   Stanley, Bruce A ^a   Kaag, Matthew ^a   Richie Jr , John P ^a   El Bayoumy, Karam ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

aging; iTRAQ; prostate lobes; proteomics; rat

Indexed keywords

ALPHA 1 ANTITRYPSIN; GLUCOSE RELATED PROTEIN; HYPOXIA UPREGULATED PROTEIN 1; LIPOCORTIN 1; PROTEIN; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL COMMUNICATION; CELL MATURATION; DEVELOPMENTAL STAGE; IMMUNITY; IMMUNOBLOTTING; INFLAMMATION; ISOBARIC TAGS FOR RELATIVE AND ABSOLUTE QUANTITATION; LIFESPAN; MALE; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE DORSOLATERAL LOBE; PROSTATE VENTRAL LOBE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; QUANTITATIVE ASSAY; RAT; REGULATORY MECHANISM;

AGING; ANIMALS; LONGEVITY; MALE; PROSTATE; PROTEOMICS; RATS; RATS, INBRED F344; TRANSCRIPTOME;

EID: 84872914177     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22576     Document Type: Article

References (67)

1. Cancer facts and figures. American Cancer Society; 2012.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ,. Cancer statistics, 2006. CA Cancer J Clin 2006; 56 (2): 106-130.
3. Isaacs JT,. The aging ACI/Seg versus Copenhagen male rat as a model system for the study of prostatic carcinogenesis. Cancer Res 1984; 44 (12 Pt 1): 5785-5796. (Pubitemid 15183594)
4. Malins DC, Johnson PM, Wheeler TM, Barker EA, Polissar NL, Vinson MA,. Age-related radical-induced DNA damage is linked to prostate cancer. Cancer Res 2001; 61 (16): 6025-6028. (Pubitemid 32762532)
5. Banerjee S, Banerjee PP, Brown TR,. Castration-induced apoptotic cell death in the Brown Norway rat prostate decreases as a function of age. Endocrinology 2000; 141 (2): 821-832. (Pubitemid 32250508)
6. Anim JT, Udo C, John B,. Characterisation of inflammatory cells in benign prostatic hyperplasia. Acta Histochem 1998; 100 (4): 439-449. (Pubitemid 28524620)
7. Banu NA, Azim FA, Kamal M, Rumi MA, Barua AR, Khan KH,. Inflammation and glandular proliferation in hyperplastic prostates: Association with prostate specific antigen value. Bangladesh Med Res Counc Bull 2001; 27 (3): 79-83.
8. De Marzo AM, Marchi VL, Epstein JI, Nelson WG,. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am J Pathol 1999; 155 (6): 1985-1992.
9. Lau KM, Tam NN, Thompson C, Cheng RY, Leung YK, Ho SM,. Age-associated changes in histology and gene-expression profile in the rat ventral prostate. Lab Invest 2003; 83 (5): 743-757. (Pubitemid 36618052)
10. Morrissey C, Buser A, Scolaro J, O'Sullivan J, Moquin A, Tenniswood M,. Changes in hormone sensitivity in the ventral prostate of aging Sprague-Dawley rats. J Androl 2002; 23 (3): 341-351. (Pubitemid 34297323)
11. Suzuki K, Oberley TD, Pugh TD, Sempf JM, Weindruch R,. Caloric restriction diminishes the age-associated loss of immunoreactive catalase in rat prostate. Prostate 1997; 33 (4): 256-263. (Pubitemid 27524705)
12. Banerjee PP, Banerjee S, Brown TR,. Increased androgen receptor expression correlates with development of age-dependent, lobe-specific spontaneous hyperplasia of the brown Norway rat prostate. Endocrinology 2001; 142 (9): 4066-4075. (Pubitemid 32802680)
13. Giri D, Ozen M, Ittmann M,. Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol 2001; 159 (6): 2159-2165. (Pubitemid 33104270)
14. Harkonen PL, Makela SI, Valve EM, Karhukorpi EK, Vaananen HK,. Differential regulation of carbonic anhydrase II by androgen and estrogen in dorsal and lateral prostate of the rat. Endocrinology 1991; 128 (6): 3219-3227.
15. Prins GS, Jung MH, Vellanoweth RL, Chatterjee B, Roy AK,. Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia. Dev Genet 1996; 18 (2): 99-106. (Pubitemid 26116854)
16. Ruffion A, Al-Sakkaf KA, Brown BL, Eaton CL, Hamdy FC, Dobson PR,. The survival effect of prolactin on PC3 prostate cancer cells. Eur Urol 2003; 43 (3): 301-308. (Pubitemid 36314244)
17. Sanchez-Visconti G, Herrero L, Rabadan M, Pereira I, Ruiz-Torres A,. Ageing and prostate: Age-related changes in androgen receptors of epithelial cells from benign hypertrophic glands compared with cancer. Mech Ageing Dev 1995; 82 (1): 19-29.
18. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR,. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59 (19): 5002-5011. (Pubitemid 29472907)
19. Parrinello S, Coppe JP, Krtolica A, Campisi J,. Stromal-epithelial interactions in aging and cancer: Senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 2005; 118 (Pt 3): 485-496. (Pubitemid 40310116)
20. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL,. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303 (5659): 848-851. (Pubitemid 38174665)
21. Bianchi-Frias D, Vakar-Lopez F, Coleman IM, Plymate SR, Reed MJ, Nelson PS,. The effects of aging on the molecular and cellular composition of the prostate microenvironment. PLoS ONE 2010; 5 (9): e12501, 1-16.
22. Bavik C, Coleman I, Dean JP, Knudsen B, Plymate S, Nelson PS,. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res 2006; 66 (2): 794-802. (Pubitemid 43165944)
23. Begley L, Monteleon C, Shah RB, Macdonald JW, Macoska JA,. CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro. Aging Cell 2005; 4 (6): 291-298.
24. Reyes I, Reyes N, Iatropoulos M, Mittelman A, Geliebter J,. Aging-associated changes in gene expression in the ACI rat prostate: Implications for carcinogenesis. Prostate 2005; 63 (2): 169-186. (Pubitemid 40525366)
25. Yamashita S, Suzuki S, Nomoto T, Kondo Y, Wakazono K, Tsujino Y, Sugimura T, Shirai T, Homma Y, Ushijima T,. Linkage and microarray analyses of susceptibility genes in ACI/Seg rats: A model for prostate cancers in the aged. Cancer Res 2005; 65 (7): 2610-2616. (Pubitemid 40490059)
26. Lam YW, Tam NN, Evans JE, Green KM, Zhang X, Ho SM,. Differential proteomics in the aging Noble rat ventral prostate. Proteomics 2008; 8 (13): 2750-2763. (Pubitemid 351988578)
27. Rao KV, Johnson WD, Bosland MC, Lubet RA, Steele VE, Kelloff GJ, McCormick DL,. Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone. Cancer Res 1999; 59 (13): 3084-3089. (Pubitemid 29316006)
28. Prins GS,. Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression. Endocrinology 1992; 130 (6): 3703-3714.
29. Wylot M, Laszczynska M, Sluczanowska-Glabowska S, Piasecka M,. Aging process of epithelial cells of the rat prostate lateral lobe in experimental hyperprolactinemia induced by haloperidol. Rocz Akad Med Bialymst 2004; 49 (Suppl. 1) 111-113.
30. Wilson MJ, Sinha AA, Powell JE, Estensen RD,. Plasminogen activator activities in the developing rat prostate. Biol Reprod 1988; 38 (3): 723-731.
31. Kwong J, Chan FL, Jiang S, Guo Y, Imasato Y, Sakai H, Koropatnick J, Chin JL, Xuan JW,. Differential expression of PSP94 in rat prostate lobes as demonstrated by an antibody against recombinant GST-PSP94. J Cell Biochem 1999; 74 (3): 406-417. (Pubitemid 29344891)
32. Banerjee S, Banerjee PP, Zirkin BR,. Cell proliferation in the dorsal and lateral lobes of the rat prostate during postnatal development. J Androl 1993; 14 (5): 310-318. (Pubitemid 23320870)
33. Ghatak S, Ho SM,. Age-related changes in the activities of antioxidant enzymes and lipid peroxidation status in ventral and dorsolateral prostate lobes of noble rats. Biochem Biophys Res Commun 1996; 222 (2): 362-367. (Pubitemid 26335021)
34. Hikosaka A, Asamoto M, Hokaiwado N, Kato K, Kuzutani K, Kohri K, Shirai T,. Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 2004; 25 (3): 381-387. (Pubitemid 38344405)
35. Reznik G, Hamlin MH II, Ward JM, Stinson SF,. Prostatic hyperplasia and neoplasia in aging F344 rats. Prostate 1981; 2 (3): 261-268. (Pubitemid 12174897)
36. Lucia MS, Bostwick DG, Bosland M, Cockett AT, Knapp DW, Leav I, Pollard M, Rinker-Schaeffer C, Shirai T, Watkins BA,. Workgroup I: Rodent models of prostate cancer. Prostate 1998; 36 (1): 49-55. (Pubitemid 28285640)
37. Bortner JD Jr, Richie JP Jr, Das A, Liao J, Umstead TM, Stanley A, Stanley BA, Belani CP, El-Bayoumy K,. Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking. J Proteome Res 2011; 10 (3): 1151-1159.
38. Tang WH, Shilov IV, Seymour SL,. Nonlinear fitting method for determining local false discovery rates from decoy database searches. J Proteome Res 2008; 7 (9): 3661-3667.
39. Kassie F, Anderson LB, Scherber R, Yu N, Lahti D, Upadhyaya P, Hecht SS,. Indole-3-carbinol inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo(a)pyrene-induced lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations in protein levels. Cancer Res 2007; 67 (13): 6502-6511. (Pubitemid 47037536)
40. Zhang J, Wang L, Anderson LB, Witthuhn B, Xu Y, Lu J,. Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model. Cancer Prev Res (Phila) 2010; 3 (8): 994-1006.
41. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, Daverman R, Diemer K, Muruganujan A, Narechania A,. PANTHER: A library of protein families and subfamilies indexed by function. Genome Res 2003; 13 (9): 2129-2141. (Pubitemid 37161770)
42. Sampson N, Untergasser G, Plas E, Berger P,. The ageing male reproductive tract. J Pathol 2007; 211 (2): 206-218. (Pubitemid 46195519)
43. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jamieson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF,. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008; 40 (3): 316-321. (Pubitemid 351311772)
44. Reeves JR, Dulude H, Panchal C, Daigneault L, Ramnani DM,. Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy. Clini Cancer Res 2006; 12 (20 Pt 1): 6018-6022. (Pubitemid 44703763)
45. Ashida S, Nakagawa H, Katagiri T, Furihata M, Iiizumi M, Anazawa Y, Tsunoda T, Takata R, Kasahara K, Miki T, Fujioka T, Shuin T, Nakamura Y,. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res 2004; 64 (17): 5963-5972. (Pubitemid 39129392)
46. Ouyang X, DeWeese TL, Nelson WG, Abate-Shen C,. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Cancer Res 2005; 65 (15): 6773-6779. (Pubitemid 41060715)
47. Haas IG,. Protein-mediated protein maturation in eukaryotes. FEBS Lett 1995; 369 (1): 72-75.
48. Daneshmand S, Quek ML, Lin E, Lee C, Cote RJ, Hawes D, Cai J, Groshen S, Lieskovsky G, Skinner DG, Lee AS, Pinski J,. Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. Hum Pathol 2007; 38 (10): 1547-1552. (Pubitemid 47418966)
49. Chang L, Jones Y, Ellisman MH, Goldstein LS, Karin M,. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev Cell 2003; 4 (4): 521-533. (Pubitemid 36437559)
50. Midorikawa Y, Tsutsumi S, Taniguchi H, Ishii M, Kobune Y, Kodama T, Makuuchi M, Aburatani H,. Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis. Jpn J Cancer Res 2002; 93 (6): 636-643. (Pubitemid 34851230)
51. Hirasawa Y, Arai M, Imazeki F, Tada M, Mikata R, Fukai K, Miyazaki M, Ochiai T, Saisho H, Yokosuka O,. Methylation status of genes upregulated by demethylating agent 5-aza-2'-deoxycytidine in hepatocellular carcinoma. Oncology 2006; 71 (1-2): 77-85.
52. Fujita A, Gomes LR, Sato JR, Yamaguchi R, Thomaz CE, Sogayar MC, Miyano S,. Multivariate gene expression analysis reveals functional connectivity changes between normal/tumoral prostates. BMC Syst Biol 2008; 2: 106.
53. Ozawa K, Kuwabara K, Tamatani M, Takatsuji K, Tsukamoto Y, Kaneda S, Yanagi H, Stern DM, Eguchi Y, Tsujimoto Y, Ogawa S, Tohyama M,. 150-kDa oxygen-regulated protein (ORP150) suppresses hypoxia-induced apoptotic cell death. J Biol Chem 1999; 274 (10): 6397-6404. (Pubitemid 29111054)
54. Gerke V, Moss SE,. Annexins: From structure to function. Physiol Rev 2002; 82 (2): 331-371. (Pubitemid 34654456)
55. Vishwanatha JK, Salazar E, Gopalakrishnan VK,. Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer 2004; 4: 8.
56. Hu N, Flaig MJ, Su H, Shou JZ, Roth MJ, Li WJ, Wang C, Goldstein AM, Li G, Emmert-Buck MR, Taylor PR,. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clin Cancer Res 2004; 10 (18 Pt 1): 6013-6022. (Pubitemid 39302608)
57. Shen D, Chang HR, Chen Z, He J, Lonsberry V, Elshimali Y, Chia D, Seligson D, Goodglick L, Nelson SF, Gornbein JA,. Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochem Biophys Res Commun 2005; 326 (1): 218-227. (Pubitemid 39573222)
58. Ornstein DK, Gillespie JW, Paweletz CP, Duray PH, Herring J, Vocke CD, Topalian SL, Bostwick DG, Linehan WM, Petricoin EF III, Emmert-Buck MR,. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 2000; 21 (11): 2235-2242. (Pubitemid 30435823)
59. Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL, Ornstein DK,. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res 2002; 8 (1): 117-123. (Pubitemid 34101466)
60. Smitherman AB, Mohler JL, Maygarden SJ, Ornstein DK,. Expression of annexin I, II and VII proteins in androgen stimulated and recurrent prostate cancer. J Urol 2004; 171 (2 Pt 1): 916-920. (Pubitemid 38090533)
61. Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA,. Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 2003; 162 (1): 255-261. (Pubitemid 36042007)
62. Hsiang CH, Tunoda T, Whang YE, Tyson DR, Ornstein DK,. The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells. Prostate 2006; 66 (13): 1413-1424. (Pubitemid 44350367)
63. Thielen JL, Volzing KG, Collier LS, Green LE, Largaespada DA, Marker PC,. Markers of prostate region-specific epithelial identity define anatomical locations in the mouse prostate that are molecularly similar to human prostate cancers. Differentiation 2007; 75 (1): 49-61. (Pubitemid 46115413)
64. Cho SY, Choi K, Jeon JH, Kim CW, Shin DM, Lee JB, Lee SE, Kim CS, Park JS, Jeong EM, Jang GY, Song KY, Kim IG,. Differential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer. Exp Mol Med 2010; 42 (4): 310-318.
65. An G, Meka CS, Bright SP, Veltri RW,. Human prostate-specific transglutaminase gene: Promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer. Urology 1999; 54 (6): 1105-1111.
66. Davies G, Ablin RJ, Mason MD, Jiang WG,. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer. J Exp Ther Oncol 2007; 6 (3): 257-264. (Pubitemid 46789726)
67. Jiang WG, Ablin RJ, Kynaston HG, Mason MD,. The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway. Microvasc Res 2009; 77 (2): 150-157.